StonvexLoading…
StonvexStonvexStonvexCore line items from HVT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $759.00M | $722.90M | $862.13M | $1.05B |
Operating Income | $26.83M | $26.15M | $72.71M | $119.50M |
Net Income | $19.73M | $19.96M | $56.32M | $89.36M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $649.05M | $648.75M | $654.13M | $649.05M |
Total Liabilities | $341.12M | $341.19M | $345.77M | $359.65M |
Cash & Equivalents | $125.33M | $120.03M | $120.64M | $123.13M |
Free Cash Flow OCF − CapEx | $32.97M | $26.82M | $44.09M | $22.60M |
Shares Outstanding | Not available | Not available | Not available | Not available |